Ipilimumab/Nivolumab Therapy in Patients With Metastatic Pancreatic or Biliary Cancer With Homologous Recombination Deficiency Pathogenic Germline Variants.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 35446342.
- Also identified by DOI 10.1001/jamaoncol.2022.0611 and PMC identifier 9026238.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This case series describes ipilimumab/nivolumab therapy in patients with metastatic pancreatic or biliary cancer with homologous recombination deficiency (HRD) pathogenic germline variants (PGVs).
Medical subject headings
- Biliary Tract Neoplasms
- Carcinoma, Renal Cell
- Kidney Neoplasms